Zydus Cadila files investigational new drug application for COVID-19 treatment
PTI, Nov 3, 2020, 11:54 AM IST
New Delhi: Drug firm Zydus Cadila on Tuesday said it has filed the investigational new drug (IND) application for ZYIL1, positioned for management of critically ill COVID-19 patients.
“Following up on its initiatives to fight COVID-19 with diagnostics, vaccines and therapeutics, the company is now focussing on cutting edge research to bring targeted therapies… it has filed the IND application of ZYIL1, a novel oral small molecule,” the company said in a regulatory filing.
Zydus Cadila said ZYIL1 will bridge a critical unmet healthcare need in several inflammatory diseases including the current pandemic of COVID-19 and address complications caused by chronic and uncontrolled inflammation.
The company said it has completed all IND enabling preclinical studies and has filed the IND application to advance this drug candidate towards the clinic.
Zydus Cadila said ZYIL1, has demonstrated promising efficacy in a number of validated pre-clinical models of Inflammatory Bowel Disease (IBD), Multiple Sclerosis (MS), Sepsis, and acute lung injury models of Acute Respiratory Distress Syndrome (ARDS).
Shares of Cadila Healthcare were trading 7.88 percent higher at Rs 442.45 apiece on BSE.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Nothing will be left for future if held private properties material resources of community: SC
Hoax bomb threat: Delhi government issues advisory for schools
Mamata raises concern over sudden rise in voter turnout, questions EVM credibility
EC bars ex-Telangana CM KCR from campaigning for 48 hours over remarks on Congress
Section of Air India Express staff flag concerns, allege mismanagement at airline
MUST WATCH
Latest Additions
BJP can’t remain with those who commit atrocities against women: Amit Shah on Prajwal Revanna
Nothing will be left for future if held private properties material resources of community: SC
Amit Shah holds road show in Haveri ahead of Karnataka’s 2nd phase Lok Sabha polls
‘Markets may extend rally this month on strong domestic eco, current govt’s potential re-election’
Hoax bomb threat: Delhi government issues advisory for schools